721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster I

Hematopoietic stem cell transplantation using briquilimab (Anti-CD117 Antibody-Conditioning), immunosuppression and TCR?B+ T-cell/CD19+ B-cell depleted haploidentical grafts in patients with fanconi anemia

Total marrow irradiation based conditioning for allogeneic hematopoietic stem cell transplantation in elderly or frail patients with hematological malignancies A single center analysis

Efficacy and safety analysis of letermovir for the prevention of CMV infection after haploidentical hematopoietic stem cell transplantation in children with acute leukemia

Efficacy and safety of luspatercept in the treatment of anemia in allo HSCT for patients with hematological diseases

A pilot study of nicotinamide riboside supplementation in allogeneic bone marrow transplantation

HLA and non HLA factors in haploidentical donor selection Insights from a brazilian single center study

Impact of HLA alloimmunization on availability of HLA well matched and mismatched unrelated allogeneic hematopoietic cell donors for transplantation

Pentostatin TBI conditioning for allogeneic transplantation in T cell lymphomas

Comorbid but transplantable Favorable outcomes with RIC and ptcy in patients with an HCT CI score of 3 or higher in the modern era

Pre HCT creatinine defines sex specific risk for severe TMA after allogeneic transplantation A report from the MIDAS consortium

Enhanced engraftment and immune recovery in thalassemia via optimized conditioning for TCRαβ depleted haploidentical transplants

Luspatercept in patients with hematological diseases who have delayed erythroid recovery after allogeneic hematopoietic stem cell transplantation

Comparative outcomes of fludarabine melphalan versus fludarabine busulfan reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies A systematic review and meta analysis

Clinical outcomes following single unrelated cord blood transplantation with ATG conditioning regimen for the treatment of mucopolysaccharidosis

Comparative analysis of efficacy and safety between high dose TMLI and TBI combined with myeloablative chemotherapy in allogeneic hematopoietic stem cell transplantation for acute leukemia with extramedullary lesions

QTc prolongation in allogeneic bone marrow transplantation Assessing cardiac complications and survival outcomes in the modern era

Conditioning with alkylating agents cytarabine cladribine hypomethylating agents and venetoclax ARCHIVE for upfront allogeneic stem cell transplantation in patients with active Acute Myeloid Leukemia or myelodysplastic syndrome with increased blasts 2

GVHD free relapse free survival in severe aplastic anemia Outcomes following allogeneic hematopoietic cell transplantation King hussein cancer center experience

Impact of oral eicosapentaenoic acid on veno occlusive disease sinusoidal obstruction syndrome onset prevention Single center retrospective analysis